Next, well compare oral and injectable semaglutide to help you determine which option might be best for your needs
Sometimes used off-label for fat loss
BMJ 338:b496
In particular, skeletal muscle loss has gained attention as a side effect associated with prognosis (Rinninella et al., 2020)
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
Overall, our results suggest that the AP is responsible for the appetite-suppressing effects of GIPR agonism but that GIP receptors in the hypothalamus underlie the ability of GIPR antagonism to enhance the weight loss effects of GLP-1R and amylin receptor agonists